We are Sorry, This Page doesn't Exist
Opioid settlement talks fail, landmark trial expected Monday
A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on a settlement on Friday that had been expected to be valued at around $50 billion......»»
Opioid settlement talks fail, landmark trial expected Monday: attorney
A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on a settlement on Friday that had been expected to be valued at up to $50 billion......»»
PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks
On Wednesday's PreMarket Prep show, earnings reports and ratings changes took a backseat to the negative news for cloud stocks and the positive news for opioid-associated drug distributors. read more.....»»
McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks
Shares of McKesson Corp. rallied 5.7% in midday trading Wednesday, enough to pace all of its larger-capitalization health care peers, after The Wall Street Journal reported that the drug distributor, and two others, were in talks.....»»
After 30 days, GM-UAW talks suddenly face a deadline. Here"s why the clock is ticking
GM's executives have until Thursday to draft a provisional plan that UAW leaders will accept and turn into a tentative agreeme.....»»
GM-UAW talks suddenly face a deadline
GM's executives have until Thursday morning to draft a provisional plan that UAW leaders will accept and turn into a tentative agreement for its members......»»
The Wall Street Journal: Major drug distributors in talks to settle opioid lawsuits for $18 billion
Three major drug distributors are in talks to pay $18 bill.....»»
Drug distributors in talks over $18B opioid settlement, WSJ reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
"Renewed Sense Of Hope": GW Pharma CEO Talks Epilepsy Drug Approval In Europe
Cannabinoid-based drug maker GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) CEO Justin Gover told CNBC's Jim Cramer the company's approval to market Epidiolex across Europe is a "histori read more.....»»
Everything Jim Cramer on "Mad Money," including Trump impeachment, Bob Iger chat, new GW Pharma drug
Jim Cramer reacts to House Speaker Nancy Pelosi's move to open an impeachment inquiry into President Donald Trump, talks with Disney CEO about his new memoir and interviews GW Pharma CEO......»»
U.S. judge approves novel framework for opioid settlement talks
A federal judge on Wednesday approved the substance of a proposal by lawyers representing cities and counties suing drug companies over the U.S. opioid epidemic that would bring every state and municipality in the country into their settlement talks......»»
Maple Leaf Motoring: TFI Buys Firm Specializing In The Transport Of Viscous Materials
Maple Leaf Motoring is a weekly rundown of developments in the world of Canadian transportation. This week: TFI buys speciality transportation firm, Mullen talks U.S. drug rules for cross-border, and CTA pushes for province-level ELD mandate. read more.....»»
Mylan"s stock soars 25% premarket after report of talks to merge off-patent drug business with Pfizer, Q2 results
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
The Wall Street Journal: Pfizer Nears Deal to Combine off-Patent Drug Business With Mylan
Pfizer Inc. is in talks to merge its off-patent drugs business with generic drugmaker Mylan NV, according to people familiar with the matter, in a deal that would create a giant global seller of lower-priced medicines......»»
Indian govt source: U.S. to seek rollback of Indian tariffs
USA-TRADE/INDIA (URGENT):U.S. to seek rollback of Indian tariffs-Indian govt source.....»»
FDA rules in favor of Lannett in dispute over cocaine product
The Food and Drug Administration denied a Citizens Petition submitted by a Lehigh Valley pharmaceutical company, which requested the FDA refuse to accept any Lannett Co. Inc. submissions seeking approval for a topical anesthesia product containing c.....»»
U.S. aims to restart China trade talks, will not accept conditions on tariff use
The United States hopes to .....»»
Mahathir urges US to talk with China, accept its greatness
Malaysian Prime Minister Mahathir Mohamad is calling for talks to resolve ongoing trade dispute between Washington and Beijing and is urging the world to accept China's technological prowess......»»
Daiichi Sankyo in talks to sell over-the-counter drug business, Bloomberg says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Markets want to see delay in tariff hikes, says Art Hogan
A U.S.-China trade deal this weekend is unlikely, National Securities chief market strategist Art Hogan tells Reuters' Fred Katayama. But he said the markets would accept a move to delay the tariff hike on Chinese goods and keep the talks going......»»